Lucinactant Patent Expiration
Lucinactant is Used for preventing respiratory distress syndrome in premature infants. It was first introduced by Lees Pharmaceutical Hk Ltd
Lucinactant Patents
Given below is the list of patents protecting Lucinactant, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Surfaxin | US5407914 | Pulmonary surfactant protein and related polypeptides |
Nov 17, 2013
(Expired) | Lees Pharm Hk |
Lucinactant's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List